Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CORAL GABLES, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical...
Month: August 2024
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung
NORWOOD, Mass., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced...
Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
SOMERSET, N.J., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell...
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
Accelerated the deployment of Nanox ARC in the US market, Submitted a new 510k application to the FDA to expand...
Entera Bio to Participate in Upcoming Investor and Scientific Conferences
JERUSALEM, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the...
Immutep Announces Late-Breaking Abstract in Head & Neck Cancer Selected for Oral Presentation at ESMO Congress 2024
Media Release Oral presentation will detail results from the randomized TACTI-003 Phase IIb trial in first line head & neck...
Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension
DUBLIN, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform...
Opus Genetics Receives Rare Pediatric Disease Designation from the U.S. FDA for Ocular Gene Therapy OPGx-LCA5 to Treat Rare Inherited Retinal Disease LCA5
Priority Review Voucher would be issued upon approval of OPGx-LCA5RESEARCH TRIANGLE PARK, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Opus...
Incyclix Bio Appoints Dr. Andrew Beelen as Vice President of Clinical Development
RESEARCH TRIANGLE PARK, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing...
LAVA Reports Second Quarter 2024 Financial Results and Business Update
Continued progress in Phase 1/2a dose escalation for LAVA-1207, including the monotherapy arm, now enrolling in dose level 12, and...
The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference
SCOTTSDALE, Ariz., Aug. 20, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care...
Infectious Disease Expert Kelly Warfield Named Sabin’s New R&D President
caption: Sabin Vaccine Institute Research & Development President Kelly Warfield WASHINGTON, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Virologist and vaccine...
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication
CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals...
Alife Health Study Shows Potential of AI Model Improving Ovarian Stimulation Decisions in IVF Treatment
SAN FRANCISCO, Aug. 20, 2024 /PRNewswire/ -- A groundbreaking study led by a team of renowned fertility specialists and data...
Hisense Partners with Black Myth: Wukong to Elevate the Gaming Experience with New Gameplay Feature
DUBAI, UAE, Aug. 20, 2024 /PRNewswire/ -- Hisense, a global leader in consumer electronics and appliances, announced its global gaming...
Bone Index Announces Successful Financing Round and Strategic Partnership with Lynx Financial
KUOPIO, Finland, Aug. 20, 2024 /PRNewswire/ -- Bone Index Finland Ltd, a pioneering company in medical technology, proudly announces the...
Bioz Announces a New Partnership With Hitachi High-Tech Enabling Real-Time Access to Scientific Citation Data
PALO ALTO, CA / ACCESSWIRE / August 20, 2024 / Bioz, Inc., a leading AI company specializing in scientific literature...
Invitation to Presentation of Senzime’s Second Quarter 2024 Report
UPPSALA, SWEDEN / ACCESSWIRE / August 20, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast...
University Lab Partners Announces the Winners of Orange County’s 2024 Pitch. Launch. Grow. Competition
IRVINE, Calif., Aug. 19, 2024 /PRNewswire/ -- University Lab Partners (ULP) is proud to announce the winners of the 4th...
Waystar Wins Stevie® Awards for Company of the Year and AI Solutions in Healthcare
Company awarded several distinctions for healthcare payments software at 2024 International Business Awards® LEHI, Utah and LOUISVILLE, Ky., Aug. 19,...